#JITC Case Report: Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response https://t.co/WbJ033aBFl https://t.co/phZ9EHEZ8m
8,024 followers
438 followers
RT @jitcancer: New #JITC Case Report: Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related a…
8,024 followers
New #JITC Case Report: Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response https://t.co/WbJ033aBFl https://t.co/ASANkHQFIM